http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Zimmer Biomet to Present at 29th Annual Piper Jaffray Healthcare Conference
-
Glenview Capital Enters Comcast (CMCSA), CVS (CVS), Twitter (TWTR) (more...) - 13F
-
Zimmer Biomet to Present at Jefferies 2017 London Healthcare Conference
-
Zimmer Biomet Reports Third Quarter 2017 Financial Results
-
Zimmer Biomet Holdings (ZBH) Launches Vitality+ and Vital Spinal Fixation Systems in U.S.
-
Zimmer Biomet Announces U.S. Launch of Vitality®+ and Vital™ Spinal Fixation Systems
-
Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of Third Quarter 2017 Results
-
Zimmer Biomet Holdings (ZBH) Launches Avenue T TLIF Cage with Integrated VerteBRIDGE Plating in U.S.
-
Zimmer Biomet Announces U.S. Launch of Avenue® T TLIF Cage with Integrated VerteBRIDGE® Plating
-
Zimmer Biomet Announces Global Launch of the Persona® Partial Knee System
-
Zimmer Biomet Holdings to Present at Morgan Stanley 15th Annual Global Healthcare Conference
-
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2017
-
Zimmer Biomet Reports Second Quarter 2017 Financial Results
-
Zimmer Biomet Holdings (ZBH) CEO Steps Down
-
Zimmer Biomet Holdings (ZBH) Sees Q2 Revenue of $1.95B
-
Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results
-
Zimmer Biomet Announces Leadership Transition
-
Zimmer Biomet Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2017 Results
-
Zimmer Biomet Introduces the World's First CE Marked, X-Ray-Based Patient Specific Instrument System for Total Knee Replacement Surgery
-
Zimmer Biomet Holdings (ZBH) Resolves FDA Warning Letter Related to Zhejiang, China Manufacturing Facility
-
Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility
-
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2017
-
Zimmer Biomet Named Top Workplace on Forbes' "America's Best Large Employers of 2017" List
-
Zimmer Biomet Holdings to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
-
Zimmer Biomet Reports First Quarter 2017 Financial Results
-
Zimmer Biomet Holdings to Present at 42nd Annual Deutsche Bank Securities Annual Health Care Conference
-
Zimmer Biomet Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2017 Results
-
Zimmer Biomet Showcases New Product Innovation, Novel Digital Health Offering and Robotic Technology at AAOS 2017
-
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2017
-
Zimmer Biomet Holdings to Present at the Cowen and Company 37th Annual Health Care Conference
-
Zimmer Biomet Announces the International Release of the Innovative Subchondroplasty® Procedure
-
Zimmer Biomet Holdings to Present at the LEERINK Partners 6th Annual Global Healthcare Conference
-
Zimmer (ZBH) Receives FDA Approval of Expanded 26-week Efficacy Claim for Gel-One Cross-Linked Hyaluronate to Treat Pain
-
Zimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One® Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis
-
Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results
-
Zimmer Biomet Holdings Announces Live Audio Webcast and Conference Call of Fourth Quarter and Full-Year 2016 Results
-
Zimmer Biomet Announces Americas Leadership Transition
-
Zimmer Biomet Holdings (ZBH) Resolves Legacy Biomet FCPA Matters with DOJ and SEC
-
Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters
-
Zimmer Biomet Holdings (ZBH) Sees Q4 Sales of $2.013B, Vs $1.97B Cons
-
Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results
-
Zimmer Biomet Holdings to Present at 35th Annual J.P. Morgan Healthcare Conference
-
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2016
-
National Joint Registry Analysis Finds Zimmer Biomet Trabecular Metal™ Cups Associated with Significantly Lower Risk of Subsequent Revision Due to Infection in Revision Hip Procedures
-
Zimmer Biomet Strengthens Spine Offering with PrimaGen Advanced™ Allograft
-
Zimmer Biomet Announces Closing of €1 Billion Senior Notes Offering and Early Settlement of Its Cash Tender Offers for Certain Outstanding Debt Securities
-
Zimmer Biomet Announces the Pricing Terms of Its Cash Tender Offers for Certain Outstanding Debt Securities
-
Zimmer Biomet Announces the Early Tender Results and Upsizing of Its Cash Tender Offers for Certain Outstanding Debt Securities
-
Zimmer Biomet Named Indo UK Institutes of Health Medicities Program's Preferred Orthopaedic Partner to Improve Delivery of Care in India
-
Zimmer Biomet Announces Cash Tender Offers for Up to $1.1 Billion Aggregate Purchase Price of Certain Outstanding Debt Securities

